Shareholders Communication Policy

We recognise the importance of good communication with the shareholders. Information in relation to us is disseminated to the shareholders in a timely manner through a number of formal channels, which include our interim and annual reports, announcements and circulars.

Our general meetings are valuable from for our board members to communicate directly with the shareholders. The shareholders are encouraged to attend our general meetings.

We are also committed to enhancing communications and relationships with its investors. Designated senior management maintains an open dialogue with institutional investors and analysts to keep them abreast of our developments.

Shareholders may at any time send their enquiries and concerns to the us in writing through our Company Secretary whose contact details are as follows:

• Address： Hussar Court, Waterlooville, South Korea, PO7 7SG, Hong Kong.
• Fax： (+852) 9289 6276
• Email： info@newagepharmaceutical.com